CN104961782B - Bioactive ingredients and its medical usage in Green Bamboo Leaf Liquor - Google Patents
Bioactive ingredients and its medical usage in Green Bamboo Leaf Liquor Download PDFInfo
- Publication number
- CN104961782B CN104961782B CN201510312849.7A CN201510312849A CN104961782B CN 104961782 B CN104961782 B CN 104961782B CN 201510312849 A CN201510312849 A CN 201510312849A CN 104961782 B CN104961782 B CN 104961782B
- Authority
- CN
- China
- Prior art keywords
- group
- bamboo leaf
- green bamboo
- compound
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000017166 Bambusa arundinacea Nutrition 0.000 title claims abstract description 123
- 235000017491 Bambusa tulda Nutrition 0.000 title claims abstract description 123
- 241001330002 Bambuseae Species 0.000 title claims abstract description 123
- 235000015334 Phyllostachys viridis Nutrition 0.000 title claims abstract description 123
- 239000011425 bamboo Substances 0.000 title claims abstract description 123
- 230000000975 bioactive effect Effects 0.000 title abstract description 7
- 239000004615 ingredient Substances 0.000 title abstract description 7
- 230000000694 effects Effects 0.000 claims abstract description 43
- 230000004224 protection Effects 0.000 claims abstract description 9
- 150000001875 compounds Chemical class 0.000 claims description 84
- 210000004185 liver Anatomy 0.000 claims description 53
- 239000003814 drug Substances 0.000 claims description 23
- 235000013305 food Nutrition 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 230000036541 health Effects 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 3
- 235000013361 beverage Nutrition 0.000 claims description 2
- 235000012970 cakes Nutrition 0.000 claims description 2
- 235000013365 dairy product Nutrition 0.000 claims description 2
- 239000006186 oral dosage form Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 235000009508 confectionery Nutrition 0.000 claims 1
- 235000013376 functional food Nutrition 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 10
- 239000003963 antioxidant agent Substances 0.000 abstract description 6
- 230000003078 antioxidant effect Effects 0.000 abstract description 6
- 235000006708 antioxidants Nutrition 0.000 abstract description 5
- 230000004957 immunoregulator effect Effects 0.000 abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 90
- 239000012452 mother liquor Substances 0.000 description 80
- 229910052799 carbon Inorganic materials 0.000 description 53
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 52
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 52
- 210000001519 tissue Anatomy 0.000 description 51
- 241000699666 Mus <mouse, genus> Species 0.000 description 47
- 230000002440 hepatic effect Effects 0.000 description 47
- 231100000753 hepatic injury Toxicity 0.000 description 47
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 39
- 210000002966 serum Anatomy 0.000 description 34
- 230000014509 gene expression Effects 0.000 description 28
- 210000000952 spleen Anatomy 0.000 description 28
- 238000005481 NMR spectroscopy Methods 0.000 description 25
- -1 flavonoid glycoside compound Chemical class 0.000 description 25
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 24
- 238000009635 antibiotic susceptibility testing Methods 0.000 description 21
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 21
- 210000003734 kidney Anatomy 0.000 description 19
- 239000000126 substance Substances 0.000 description 19
- VZGDMQKNWNREIO-UHFFFAOYSA-N carbon tetrachloride Substances ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 18
- 210000001541 thymus gland Anatomy 0.000 description 18
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 17
- 241000699670 Mus sp. Species 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- 206010028851 Necrosis Diseases 0.000 description 16
- 238000003919 heteronuclear multiple bond coherence Methods 0.000 description 16
- 230000017074 necrotic cell death Effects 0.000 description 16
- 230000001681 protective effect Effects 0.000 description 16
- 238000011160 research Methods 0.000 description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- 235000001727 glucose Nutrition 0.000 description 15
- 210000005229 liver cell Anatomy 0.000 description 15
- 230000001154 acute effect Effects 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 14
- 239000008103 glucose Substances 0.000 description 14
- 230000008595 infiltration Effects 0.000 description 14
- 238000001764 infiltration Methods 0.000 description 14
- 230000003859 lipid peroxidation Effects 0.000 description 14
- 229940079593 drug Drugs 0.000 description 13
- 229930182470 glycoside Natural products 0.000 description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 13
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 108010062580 Concanavalin A Proteins 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 238000000926 separation method Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000001142 circular dichroism spectrum Methods 0.000 description 11
- 208000033065 inborn errors of immunity Diseases 0.000 description 11
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 11
- 238000001228 spectrum Methods 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 10
- 210000005228 liver tissue Anatomy 0.000 description 10
- 102000015212 Fas Ligand Protein Human genes 0.000 description 9
- 108010039471 Fas Ligand Protein Proteins 0.000 description 9
- 241001529936 Murinae Species 0.000 description 9
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical group [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 9
- 108090001005 Interleukin-6 Proteins 0.000 description 8
- 206010067125 Liver injury Diseases 0.000 description 8
- 241000270295 Serpentes Species 0.000 description 8
- 238000001425 electrospray ionisation time-of-flight mass spectrometry Methods 0.000 description 8
- 238000010828 elution Methods 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- 150000002338 glycosides Chemical class 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 210000003462 vein Anatomy 0.000 description 8
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 7
- 101100068867 Caenorhabditis elegans glc-1 gene Proteins 0.000 description 7
- 229920000742 Cotton Polymers 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 238000001052 heteronuclear multiple bond coherence spectrum Methods 0.000 description 7
- 238000005160 1H NMR spectroscopy Methods 0.000 description 6
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 6
- 102100037850 Interferon gamma Human genes 0.000 description 6
- 108010074328 Interferon-gamma Proteins 0.000 description 6
- 229940125904 compound 1 Drugs 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 230000007170 pathology Effects 0.000 description 6
- 239000003208 petroleum Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 5
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 5
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 5
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 102000055102 bcl-2-Associated X Human genes 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 229940125782 compound 2 Drugs 0.000 description 5
- 230000008878 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 210000003494 hepatocyte Anatomy 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 235000010335 lysozyme Nutrition 0.000 description 5
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 230000001007 puffing effect Effects 0.000 description 5
- 238000010898 silica gel chromatography Methods 0.000 description 5
- 102000016943 Muramidase Human genes 0.000 description 4
- 108010014251 Muramidase Proteins 0.000 description 4
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 4
- 230000006907 apoptotic process Effects 0.000 description 4
- 239000000544 cholinesterase inhibitor Substances 0.000 description 4
- 229940126214 compound 3 Drugs 0.000 description 4
- 229940125898 compound 5 Drugs 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 229960000274 lysozyme Drugs 0.000 description 4
- 239000004325 lysozyme Substances 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000013246 thioacetic acid model Methods 0.000 description 4
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 3
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 3
- HCCNBKFJYUWLEX-UHFFFAOYSA-N 7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)-3-(pyrazin-2-ylmethylamino)pyrido[3,4-b]pyrazin-2-one Chemical compound O=C1N(CCOCCC)C2=CC(C=3C=NC(OC)=CC=3)=NC=C2N=C1NCC1=CN=CC=N1 HCCNBKFJYUWLEX-UHFFFAOYSA-N 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 3
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 description 3
- 240000006365 Vitis vinifera Species 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- 125000000188 beta-D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
- 229940126543 compound 14 Drugs 0.000 description 3
- 229940126142 compound 16 Drugs 0.000 description 3
- 229940126545 compound 53 Drugs 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 150000002303 glucose derivatives Chemical class 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 210000004969 inflammatory cell Anatomy 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000001539 phagocyte Anatomy 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 150000003505 terpenes Chemical class 0.000 description 3
- AAWZDTNXLSGCEK-WYWMIBKRSA-N (-)-quinic acid Chemical class O[C@@H]1C[C@](O)(C(O)=O)C[C@@H](O)[C@H]1O AAWZDTNXLSGCEK-WYWMIBKRSA-N 0.000 description 2
- SEBFKMXJBCUCAI-WAABAYLZSA-N (2r,3r)-3,5,7-trihydroxy-2-[(2s,3s)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one Chemical group C1=C(O)C(OC)=CC([C@H]2[C@@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-WAABAYLZSA-N 0.000 description 2
- 0 CC(C[C@@](*C1(*)S)O)=C1C(Oc1ccc(*)cc1)=C Chemical compound CC(C[C@@](*C1(*)S)O)=C1C(Oc1ccc(*)cc1)=C 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- OEYQBKYISMRWQB-UHFFFAOYSA-N Santal Chemical compound C=1C(OC)=CC(O)=C(C2=O)C=1OC=C2C1=CC=C(O)C(O)=C1 OEYQBKYISMRWQB-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 229960004397 cyclophosphamide Drugs 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- QDOXWKRWXJOMAK-UHFFFAOYSA-N dichromium trioxide Chemical compound O=[Cr]O[Cr]=O QDOXWKRWXJOMAK-UHFFFAOYSA-N 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 229930182486 flavonoid glycoside Natural products 0.000 description 2
- 150000002241 furanones Chemical class 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 206010019692 hepatic necrosis Diseases 0.000 description 2
- 230000003118 histopathologic effect Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 2
- 230000004660 morphological change Effects 0.000 description 2
- 239000010413 mother solution Substances 0.000 description 2
- 125000005704 oxymethylene group Chemical group [H]C([H])([*:2])O[*:1] 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 150000007965 phenolic acids Chemical class 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229960001866 silicon dioxide Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- YUKQRDCYNOVPGJ-UHFFFAOYSA-N thioacetamide Chemical compound CC(N)=S YUKQRDCYNOVPGJ-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- ZQPVHVKWCGZNDW-NVYKSAHZSA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](OC)O[C@@H]1CO[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ZQPVHVKWCGZNDW-NVYKSAHZSA-N 0.000 description 1
- LDFBJPNPWVPKAQ-MRVPVSSYSA-N (5R)-(2E)-5-hydroxy-2-methyl-hepta-2-ene-1,6-dione Natural products CC(=O)[C@H](O)CC=C(C)C=O LDFBJPNPWVPKAQ-MRVPVSSYSA-N 0.000 description 1
- 238000005084 2D-nuclear magnetic resonance Methods 0.000 description 1
- OLNCJMCWTONFER-TVKJYDDYSA-N 3-phenyl-1-[(2S,3R,4S,5S,6R)-2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]prop-2-en-1-one Chemical compound C(C=CC1=CC=CC=C1)(=O)[C@]1(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO OLNCJMCWTONFER-TVKJYDDYSA-N 0.000 description 1
- JRLTTZUODKEYDH-UHFFFAOYSA-N 8-methylquinoline Chemical group C1=CN=C2C(C)=CC=CC2=C1 JRLTTZUODKEYDH-UHFFFAOYSA-N 0.000 description 1
- 241000195622 Astasia Species 0.000 description 1
- 102000003914 Cholinesterases Human genes 0.000 description 1
- 108090000322 Cholinesterases Proteins 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 229930185098 Epijasminoside Natural products 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 230000010718 Oxidation Activity Effects 0.000 description 1
- LBTAFDHXNSPZSZ-QLDIZCGWSA-M Picrocrocinic acid Natural products O=C([O-])C=1C(C)(C)C[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)CC=1C LBTAFDHXNSPZSZ-QLDIZCGWSA-M 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 101710170789 Protein bax Proteins 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- OHVGNSMTLSKTGN-BTVCFUMJSA-N [C].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O Chemical group [C].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O OHVGNSMTLSKTGN-BTVCFUMJSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- DNKKYCZQRCVIOK-UHFFFAOYSA-N anisole;prop-2-enoic acid Chemical group OC(=O)C=C.COC1=CC=CC=C1 DNKKYCZQRCVIOK-UHFFFAOYSA-N 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 150000001555 benzenes Chemical group 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 229940048961 cholinesterase Drugs 0.000 description 1
- 230000003153 cholinolytic effect Effects 0.000 description 1
- 150000004777 chromones Chemical class 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- NBGJGWFIDMDCAW-UHFFFAOYSA-N egonol-beta-gentiobioside Natural products C=1C=2C=C(C=3C=C4OCOC4=CC=3)OC=2C(OC)=CC=1CCCOC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O NBGJGWFIDMDCAW-UHFFFAOYSA-N 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- LBTAFDHXNSPZSZ-UHFFFAOYSA-N ent-16beta,17-Dihydroxykauran-19-oic acid 16alpha,17-acetonide Natural products C1C(C)=C(C(O)=O)C(C)(C)CC1OC1C(O)C(O)C(O)C(CO)O1 LBTAFDHXNSPZSZ-UHFFFAOYSA-N 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 239000002038 ethyl acetate fraction Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 108010052621 fas Receptor Proteins 0.000 description 1
- 102000018823 fas Receptor Human genes 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 210000000540 fraction c Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 150000002304 glucoses Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 238000000990 heteronuclear single quantum coherence spectrum Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- XBRXLXOCHNGHBC-UHFFFAOYSA-N jasminoside B Natural products CC1(C)CC(=O)C=C(COC2OC(CO)C(O)C(O)C2O)C1CO XBRXLXOCHNGHBC-UHFFFAOYSA-N 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 231100000149 liver necrosis Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229930182487 phenolic glycoside Chemical class 0.000 description 1
- 150000007950 phenolic glycosides Chemical class 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- HTBCLXGPPMFWTA-UHFFFAOYSA-N undeca-4,6-dien-3-one Chemical compound CCCCC=CC=CC(=O)CC HTBCLXGPPMFWTA-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/258—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing —CHO groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/78—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C07H1/08—Separation; Purification from natural products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to the bioactive ingredients in Green Bamboo Leaf Liquor and health-care effect, in particular to the bioactive ingredients in Green Bamboo Leaf Liquor with immunoregulatory activity, anti-oxidant, anti-inflammatory, protection hepar damnification.
Description
Technical field
The present invention relates to the bioactive ingredients in Green Bamboo Leaf Liquor and health-care effect, in particular to having in Green Bamboo Leaf Liquor
Immunoregulatory activity, anti-oxidant, anti-inflammatory, the bioactive ingredients for protecting hepar damnification.
Background technology
Green Bamboo Leaf Liquor is China's traditional history famous brand of wine, and Chinese win high praise highest and most health liquors.It is with China
Delicate fragrance type famous brand of wine --- Fenyang wine is base liquor, with the pleasant impression rare Chinese medicine of the leaf of bamboo, Radix Angelicae Sinensis, dried orange peel, cape jasmine, fructus amomi, santal, cloves etc. ten
A kind of alcoholic drink mixed with fruit juice that the soak and rock sugar of material are formulated.The drinking utensils has blood-nourishing and stomach, helped digestion, relieving restlessness and other effects.It is throughout the year suitable
Amount is drunk, can reconcile internal organs, dredge gas blood-nourishing, the fiery dissolving phlegm that disappears, removing toxic substances diuresis, invigorating the spleen nourishing liver.Not only can may be used also with health of body
To prevent diseases such as curing arthritis, hypertension, highs fat of blood.
In recent years, with the continuous enhancing of consumer health's health care consciousness, special efficacy composition for health food and
Its health-care effect, also increasingly cause the concern of people.Therefore, it is deep to bioactive ingredients progress system in Green Bamboo Leaf Liquor
Research, attempt to excavate, inquire into its distinctive health function, there is important theory significance and actual application value.
The content of the invention
The purpose of the present invention:Chemical composition in the research Green Bamboo Leaf Liquor of systematic science, finds new activated monomer chemical combination
Thing.
The implementation process of invention is as follows:
Include silica gel column chromatography, macroporous absorbent resin, polyamide, sephadex lh-20 post with various separation means
Chromatogram and preparative high performance liquid chromatography etc., isolated 96 compounds from Green Bamboo Leaf Liquor, wherein 16 terpenoids
Thing, 10 iridoids, 25 flavones and flavonoid glycoside compound, 3 chromogen ketone compounds, 15 phenolic acid and
Phenol glycosides compound, 14 aromatic compounds, 1 chinic acid class, 2 Coumarinses, 2 lignanoids, 3 steroids, 2
Individual long-chain fat acids, 2 furfural classes, 1 Furanones.Wherein compound 1,2,3,4,5,14,16,53 for new chemistry into
Point.
Its chemical name of these compounds and structural formula are as follows:
Compound 1:The ring [5.4.0] 11 of (1R, 10S, 11R) -10,11- dimethyl -4- aldehyde radical -2,9- dioxos-two -
4,6- diene -3- ketone, [(1R, 10S, 11R) -10,11-dimethyl-4-formyl-2,9-dioxa-bicyclo [5.4.0]
Undeca-4,6-dien-3-one], there is structure shown in structural formula 1.
Compound 2:6- (6- (3,4- dimethoxys) phenylpropenoyl-β-D-Glucose base)-O- β-D-Glucose first glycosides
[methyl-6-(6-(3,4-dimethoxy)-benzalacryloyl-β-D-glucosyl)-O-β-D-
Glucopyranoside], there is structure shown in structural formula 2.
Compound 3:(4- hydroxyl -2,6,6- trimethyls)-cyclohexenecarboxylic acid -4- hydroxyls-(benzoic acid) ester
[Picrocrocinic ester], there is structure shown in structural formula 3.
Compound 4:(7R) -6 '-O- (3 "-methoxyl group -4 "-hydroxyl-phenylpropenoyl)-β-- O-7- the hydroxyls of D-Glucose -1 '
Methyl-(6- methylol -1,1- dimethyleyelohexane -4- alkene -3- ketone) glycosides [6'-O- (3-methoxyl-4-hydroxyl-
Coumaroyl)-epijasminoside B], there is structure shown in structural formula 4.
Compound 5:(4R) -3- methylol -4- methylol -5,5- dimethyleyelohexane -2- ketenes-β-D-Glucose glycosides
[epijasminoside B], there is structure shown in structural formula 5.
Compound 14:(5R)-(2E) -5- hydroxy-2-methyls-amyl- 2- alkene -1,6- diketone [(5R)-(2E) -5-
Hydroxy-2-methyl-hepta-2-ene-1,6-dione], there is structure shown in structural formula 6.
Compound 16:Trans-p- methoxyl groups of 6 "-O--cinnamyl group Geniposide O-gentibioside [6 "-O-trans-p-
Methoxyl-coumaroylgenipin gentiobioside], there is structure shown in structural formula 7.
Compound 53:7- methoxyl groups-Isobiflorin [7-methoxyl-isobiflorin], there is the institute of structural formula 8
Show structure.
It is isolated from Green Bamboo Leaf Liquor it is another object of the present invention to provide Green Bamboo Leaf Liquor involved in the present invention
Compound medical usage.
The present invention has found that Green Bamboo Leaf Liquor, isolated compound has anti-oxidant from Green Bamboo Leaf Liquor by research, resists
Inflammation, Immune-enhancing effect, protection liver effect.It can be used for preparing medicine or health food of the prevention and treatment with above-mentioned effect.
The present invention also provides the medicine or health care food of isolated compound containing Green Bamboo Leaf Liquor or from Green Bamboo Leaf Liquor
Product composition, to be adapted to application.
Its suitable form of described pharmaceutical composition includes any dosage form suitably taken, such as the present invention
Pharmaceutical composition, can be prepared into pharmaceutical dosage forms, such as oral dosage form as needed when in use, injection form,
External preparation form, suppository form etc..
The health-care food composition, including but not limited to following food form:Beverage, dairy products, bread, cake, sugar
Fruit etc..
Preferably, the present invention provides above-mentioned 8 kinds of compounds, their preparation, and they are preparing medicine or health care food
Application in product.
The present invention has found that Green Bamboo Leaf Liquor has anti-oxidant, anti-inflammatory, Immune-enhancing effect, protects liver effect by research, wherein
Terpene, iridoids, flavonoids and phenolic acid compound are its principle active component.Bioactivity research shows, compound
Any compound has anti-oxidant, anti-inflammatory, removes free radical, anticholinesterase, Immune-enhancing effect, protection liver effect in 1-98,
It is the material base that Green Bamboo Leaf Liquor plays healthcare function.
The implementation process of invention is as follows:
Establish acute hepatic injury model (chemical liver injury, Immune liver injury, the wine of different damage mechanisms
Essence liver injury model, liver lesion induced by drugs wound model), the research of Hepatocyte protection has been carried out to Green Bamboo Leaf Liquor.Establish immunity
Low model, study the immunoregulatory activity of Green Bamboo Leaf Liquor.The cellular damages of HepaG 2 are induced using alcohol, screening liver cell protects
Protect composition.The anti-inflammatory activity of compound in Green Bamboo Leaf Liquor is studied using LPS inductions RAW 264.7.To getting in Green Bamboo Leaf Liquor
Compound carries out the screening of cholinesterase activity.
Brief description of the drawings
CD the and UV collection of illustrative plates of Fig. 1 compounds 1
CD the and UV collection of illustrative plates of Fig. 2 compounds 2
CD the and UV collection of illustrative plates of Fig. 3 compounds 3
CD the and UV collection of illustrative plates of Fig. 4 compounds 4
CD the and UV collection of illustrative plates of Fig. 5 compounds 7
Fig. 6 CCl4Hepatic tissue pathology change HE dyeing (100 ×) (A) normal groups of caused acute liver;
(B)CCl4Model group;(C)-(F) is respectively green bamboo snake mother liquor A-D dosage groups
Hepatic tissue pathology change HE dyeing (100 ×) (A) normal groups of acute liver caused by Fig. 7 TAA;(B)
TAA model groups;(C)-(F) is respectively green bamboo snake mother liquor A-D dosage groups;(G) Compound Liver-benepitino Remedy group (200mg/kg)
Hepatic tissue pathology change HE dyeing (× 100) (A) normal groups of acute liver caused by Fig. 8 alcohol;
(B) alcohol model group;(C)-(F) is respectively Green Bamboo Leaf Liquor mother liquor A-D dosage groups;(G) it is DDB group (150mg/kg)
Acute liver hepatic tissue TNF-α expression (× 200) (A) normal group caused by Fig. 9 alcohol;(B) alcohol mould
Type group;(C)-(F) is respectively Green Bamboo Leaf Liquor mother liquor A-D dosage groups;(G) it is DDB group (150mg/kg)
Acute liver hepatic tissue Fas expression (× 200) (A) normal groups caused by Figure 10 alcohol;(B) alcohol mould
Type group;(C)-(F) is respectively Green Bamboo Leaf Liquor mother liquor A-D dosage groups;(G) it is DDB group (150mg/kg)
Acute liver hepatic tissue FasL expression (× 200) (A) normal groups caused by Figure 11 alcohol;(B) alcohol mould
Type group;(C)-(F) is respectively Green Bamboo Leaf Liquor mother liquor A-D dosage groups;(G) it is DDB group (150mg/kg)
Acute liver hepatic tissue Bcl-2 expression (× 200) (A) normal groups caused by Figure 12 alcohol;(B) alcohol
Model group;(C)-(F) is respectively Green Bamboo Leaf Liquor mother liquor A-D dosage groups;(G) it is DDB group (150mg/kg)
Acute liver hepatic tissue Bax expression (× 200) (A) normal groups caused by Figure 13 alcohol;(B) alcohol mould
Type group;(C)-(F) is respectively Green Bamboo Leaf Liquor mother liquor A-D dosage groups;(G) it is DDB group (150mg/kg)
The extraction flow chart of Figure 14 Green Bamboo Leaf Liquors
Figure 15 Green Bamboo Leaf Liquor HPD10060% ethanol elutions are partially separated flow chart
Figure 16 Green Bamboo Leaf Liquors chloroform and ethyl acetate extraction part separation process figure
The related figures of the HMBC of Figure 17 compounds 1
The relative configuration figure of Figure 18 A compounds 1, the relative configuration figure of Figure 18 B compounds 1
The HMBC figures of Figure 19 A compounds 2, the NOEs figures of Figure 19 B compounds 2
The related figures of the HMBC of Figure 20 A compounds 3, the related figures of HMBC of Figure 20 B compounds 3, the HMBC of Figure 20 C compounds 3
Correlation figure
The related figures of the HMBC of Figure 21 A compounds 4, the related figures of HMBC of Figure 21 B compounds 4
The related figures of the HMBC of Figure 22 A compounds 5, the related figures of HMBC of Figure 22 B compounds 5
The related figures of the HMBC of Figure 23 compounds 14
The related figures of the HMBC of Figure 24 compounds 16
Embodiment
The present invention is further illustrated by the following examples, but not as limitation of the present invention.
Embodiment 1:The separation of compound
After taking Green Bamboo Leaf Liquor mother liquor, concentration to fling to alcohol, extracted successively with petroleum ether, chloroform, ethyl acetate, extract 5 respectively
Time, each extract layer solvent is reclaimed, obtains each extract layer medicinal extract:Petroleum ether layer 100g, chloroform layer 56g, ethyl acetate layer 100g.
Water layer HPD after extraction100Macroporous absorbent resin is handled, and is entered successively with water, 60% ethanol, 95% ethanol
Row elution, wherein water-wash section discards, and 60% ethanol is separately recovered, 95% ethanol elution part obtains medicinal extract:60% ethanol elution
Part 200g, 95% ethanol elution part 20g.Extraction separation process is shown in Figure 14.
Chloroform layer, ethyl acetate layer sample are merged, sample 100g after merging is taken, utilizes silica gel column chromatography repeatedly, polyamides
50 compounds are obtained in the separation of the means such as amine, Sephadex LH-20 and HPLC;Take HPD100Macroporous absorbent resin 60%
EtOH elution fraction sample 100g, utilize isolated 48 compounds of means such as silica gel column chromatography, open ODS and HPLC.Point
See Figure 15 from flow, 16.
Wherein 8 noval chemical compounds of the invention, compound 1,2,3,4,5,14,16,53 specific separation method descriptions are such as
Under:
Ethyl acetate fraction (100g) is with petroleum ether/acetone (100:0-0:100) silicagel column is carried out for eluting solvent
Chromatograph (350g, 200-300 mesh, 9 × 160cm), fraction A-O must be eluted.Fraction I (petroleum ether/acetone, 100:15,2.3g) and
Fraction M (petroleum ether/acetone, 100:50,3.0g) merging carries out half preparation HPLC separation (acetonitrile/water, 15/85) and obtains compound 3
(18mg)。
60% alcohol elution (100g) is with chloroform/methanol (100:0-0:100) silica gel column layer is carried out for eluting solvent
Analyse (350g, 200-300 mesh, 9 × 160cm), fraction a-m must be eluted.Fraction b (chloroform/methanol, 100:0.5,70mg) with oil
Ether/acetone carries out silica gel column chromatography, obtains fraction b1-b3.Fraction b2, which carries out half preparation HPLC separation (methanol/water, 4/96), to be changed
Compound 6 (3.0mg).
Fraction c (chloroform/methanol, 100:2,2.0g) carry out half preparation HPLC separation (acetonitrile/water, 6/94) and obtain compound 1
(5.1mg).Fraction e (chloroform/methanol, 100:3 and 100:5) with methanol/water (15:85-40:60, v/v) ODS gradients are carried out to wash
Take off to obtain five parts, e1-e5.Fraction e1 (methanol/water, 15:85,38.9mg) carry out half prepare HPLC separation (acetonitrile/water, 20/
80) compound 2 (3.5mg) is obtained.
Fraction f (chloroform/methanol, 100:8,3.0g) with methanol/water (5:95-50:50, v/v) ODS gradient elutions are carried out to obtain
Six part f1-f6.Fraction f2 (methanol/water, 10:90,52.6mg) half preparation HPLC separation (acetonitrile/water, 5/95) is carried out to obtain
Compound 4 (4.2mg), compound 5 (3.0mg) and compound 8 (8.5mg).
Fraction g (chloroform/methanol, 100:12) silica gel column chromatography is carried out as eluting solvent using chloroform/methanol and obtains three fractions
g1-g3.Fraction g2 carries out half preparation HPLC separation (acetonitrile/water, 21/79) and obtains compound 7 (4.5mg).
Embodiment 2:Identification of chemical structure
Using 1 dimension, 2 dimension nuclear magnetic resoance spectrums (1D, 2D-NMR), mass spectrum (MS), the spectrum means such as circular dichroism spectra (CD) and
Other physico-chemical processes determine the chemical constitution of 96 isolated compounds.Including 8 noval chemical compounds
Chemical constitution and identification of means such as table 1:
The structure and its authentication method of 96 compounds (including 8 noval chemical compounds) in the Green Bamboo Leaf Liquor of table 1
* it is noval chemical compound
Embodiment 3:The Identification of chemical structure of compound 1
Yellow transparent solid body (methanol), is dissolved in methanol.HR-ESI-TOF-MS spectrums provide high-resolution quasi-molecular ion peak m/
z223.0973[M+H]+(Calcd.223.0970,1.3ppm).With reference to its NMR data, its molecular formula C is determined12H14O4, and count
Calculate the compound and contain 6 degrees of unsaturation.
1H H NMR spectroscopies (600MHz, CD3OD), low field area provides 2 alkene Hydrogen Proton signal δ 6.35 (1H, d, J=4.2Hz),
7.15 (1H, d, J=4.2Hz);1 active hydrogen proton signal δ 9.33 (1H, s).High field region provides 2 company's oxygen tertiary carbon proton letters
Number δ 5.23 (1H, d, J=11.4Hz), 4.34 (1H, dq, J=3.0,6.0Hz);1 company oxygen secondary carbon proton signal δ 4.65 (2H,
s);1 tertiary carbon proton signal δ 2.65 (1H, m), two methyl proton signal δ 1.13 (3H, d, J=6.0Hz), 1.55 (3H, d, J
=6.0Hz).
13C H NMR spectroscopies (150MHz, CD3OD 12 carbon signals are provided in), low field area provides 6 sp2The carbon signal of hydridization,
An aldehyde radical carbon signal is wherein provided at δ 180.5, is the carbonyl carbon signals of one one-tenth ester at δ 174.6.δ 111.9,128.3,133.4,
Two double bond carbon signals are provided at 146.3.Two company's oxygen methine carbon signals are provided at high field region δ 82.3,63.8, at δ 56.8
1 company's Oxymethylene carbon signal is provided, 1 methine carbon signal is provided at δ 45.3, two methyl carbon are provided at δ 14.7,18.8
Signal.
In HMBC spectrums (Figure 17), by δ 1.13 (3H, d, J=6.0Hz), 1.55 (3H, d, J=6.0Hz) respectively with δ
45.3,63.8,82.3 have correlation, and δ 4.34 (1H, dt, J=3.0,6.6Hz) is related to δ 14.7, δ 2.65 (1H, m) and δ
14.7,18.8,63.8,82.3 is related, illustrates that 14.7 methyl is connected on 82.3 company's oxygen tertiary carbon, 18.8 methyl is connected in 45.3
Tertiary carbon on.There are long-range correlation, δ 5.23 (1H, d, J=11.4Hz) and δ 14.7 by δ 4.65 (2H, s) and δ 111.9,146.3,
45.3,133.4,146.3,174.6 is related, and δ 6.35 (1H, d, J=4.2Hz) and δ 56.8,128.3,133.4,146.3 is related,
δ 7.15 (1H, d, J=4.2Hz) and δ 111.9,133.4,146.3,180.5 is related, can draw the planar structure of the compound such as
Fig. 1.In addition, being J=11.4Hz according to H-10/H-11 coupling constant, H10/H-9 coupling constant is J=3.0Hz, and profit
With computer model configuration least energy (CS Chem 3D Pro Version 8.0, MM2minimize energy
Caculate) calculate, relative configuration such as Figure 18 of the compound can be drawn, be named as 10,11- dimethyl -4- aldehyde radicals -2,9- bis-
- 4,6- diene -3- the ketone of the ring of oxo-two [5.4.0] 11.
In CD is composed (see accompanying drawing 1), according to the spiral of unsaturated lactone rule, compound 1 is presented just at 306nm
Cotton effects, negative cotton effects are presented at 260nm, can determine whether to meet P- spirals, therefore judge 1 for R types, determine compound
1 absolute configuration is (1R, 10S, 11R).Retrieved through system documentation, to have no the noval chemical compound of document report, its structure is
- 4,6- diene -3- the ketone of-two ring [5.4.0] of (1R, 10S, 11R) -10,11- dimethyl -4- aldehyde radical -2,9- dioxos 11.
The compound 1 of table 21H NMR(600MHz in CD3OD),13C NMR(150MHz in CD3) and HMBC data OD
Embodiment 4:The Identification of chemical structure of compound 2
White powder (methanol), is soluble in methanol, insoluble in petroleum ether, ethyl acetate, chloroform.HR-ESI-TOF-MS is composed
Provide high-resolution quasi-molecular ion peak m/z 545.1877 [M-H]-(Calcd.545.1870,0.5ppm).With reference to its NMR number
According to it is C to determine its molecular formula24H34O14, and calculate the compound and contain 8 degrees of unsaturation.
1H H NMR spectroscopies (400MHz, CD3OD 1 group 1 " ' is provided in), 3 " ', 4 " '-trisubstituted benzene ring proton signal δ 6.90 (2H,
S, H-2 " ', 6 " '), δ 7.48 (1H, s, H-5 " '), 2 with carboxyl conjugation trans double bond proton signal δ 6.38 (1H, d, J=
16.0Hz, H- α), δ 7.59 (1H, d, J=16.0Hz, H- β), 3 methoxy proton signal δ 3.71 (3H, s), δ 3.88 (3H,
S), δ 3.86 (3H, s), by β-D-Glucose anomeric proton signal δ 4.98 (1H, d, J=8.0Hz, glc-1) and acylated Portugal
Grape 6 proton signal δ 4.26 (1H, br.d, J=14.4Hz, glc-6) of sugar, δ 4.18 (1H, br.d, J=14.4Hz, glc-6)
And by another β-D-Glucose anomeric proton signal δ 4.71 (1H, d, J=8.0Hz, glc-1) and the grape to low field displacement
Sugared 6 proton signal δ 4.47 (1H, dd, J=11.2,6.0Hz, glc-6), δ 4.39 (1H, dd, J=11.2,2.4Hz, glc-
6), thus it is speculated that the glucose 6 is substituted by glucosyl group, and forms first glycosides.
13C H NMR spectroscopies (100MHz, CD3OD provided in) and share 24 carbon signals, low field shows 9 sp2The carbon letter of hydridization
Number, wherein δC168.9 be carbonyl carbon signals.With reference to1H H NMR spectroscopies speculate that wherein 11 carbon signals are shown as 3 " ', 4 " '-dimethoxy
Base benzene acryloyl structural framework, remaining 13 carbon signal are shown as carbon signal on two β-D-Glucoses and methoxyl group
Carbon signal.
δ is understood by HSQC spectrumC51.9 (C-1), 57.0 (C-3 " '), 57.0 (C-4 " ') are three methoxyl group carbon signals,
δC61.9 (C-6 "), 64.2 (C-6') two secondary carbon signals are respectively six carbon signals on two β-D-Glucoses, δC
100.6 (C-1'), 99.4 (C-1 ") two tertiary carbon signals are respectively the end group carbon signal on two β-D-Glucoses, δC 145.0
(C- β), 115.8 (C- α) are respectively and the carbon signal in the trans double bond of carboxyl conjugation, δC128.5 (C-1 " '), 149.5 (C-
3 " '), 149.4 (C-4 " ') are the nuclear substituted quaternary carbon signal of benzene, δC106.9 (C-2 " ', 6 " '), 112.4 (C-5 " ') are
3 " ', three unsubstituted carbon signals in 4 " '-dimethoxy benzene acryloyl structural framework.
In HMBC spectrum (Figure 19), methoxyl group proton δH3.65 with δC100.6 (C-1') are related, infer that C-1 is connected to
On the end group of β-D-Glucose, first glycosides is formed.Methoxyl group proton δH3.86 and 3.88 respectively with δC149.4 (C-4 " '), 149.5
There is long-range correlation in (C-3 " '), illustrate that the two methoxyl groups are connected on phenyl ring C-4 " ', C-3 " ' positions.6 matter of glucose
Subsignal δH4.39 with δC99.4 (C-1 ") have correlation, show that 6 of this glucose are connected with 1 of another β-D-Glucose.
6 proton signal δ of another β-D-GlucoseH4.26 with δC168.9 (C-9 " '), 115.8 (C-8 " ') are related, that is, illustrate this
Glucose 6 is connected on phenylpropenoyl.In addition, phenyl ring proton signal δH6.90 with δC128.5 (C-1 " '), 149.5 (C-
3 " ') long-range correlation be present in, 149.4 (C-4 " '), 145.0 (C-7 " ').
In NOESY spectrum (Figure 19), H-1/H-1' is related, it is known that the end group of β-D-Glucose is substituted by methyl, is formed
First glycosides.H-6'/H-1 " is related, illustrates that 6 of this β-D-Glucose are connected with the end group of another glucose.H-6 "/H-8 " ', H-
6 "/H-2 " ' is related, shows that this glucose 6 is connected with phenylpropenoyl.In addition, H-8 " '/H-2 " ', H-7 " '/H-6 " ' phase
Close, NOESY effects can combine simultaneously1H NMR coupling constant judges C- α, and C- β double bonds are trans double bond.
Therefore, to sum up analyze, can determine that the compound is 6- (6- (3,4- dimethoxy) phenylpropenoyl-β-D- grapes
Glycosyl)-O- β-D-Glucose first glycosides.
The compound 2 of table 31H NMR(400MHz in CD3OD),13C NMR(100MHz in CD3OD),HMBC,NOESY
Spectrum
Embodiment 5:The Identification of chemical structure of compound 3
Yellow powder (methanol), is dissolved in methanol.HR-ESI-TOF-MS spectrums provide high-resolution quasi-molecular ion peak m/z
303.1225[M-H]-(Calcd.303.1232,-1.9ppm).With reference to its NMR data, it is C to determine its molecular formula17H20O5, and
Calculate the compound and contain 8 degrees of unsaturation.
1H H NMR spectroscopies (600MHz, CD3OD in), low field area provides the phenyl ring proton signal δ of one group of AA'BB' Coupling System
6.84 (2H, dd, J=2.4,8.4Hz), 6.84 (2H, dd, J=2.4,8.4Hz).High field region provides 3 methyl proton signal δ
1.09 (3H, s), 1.21 (3H, s), 1.72 (3H, s).Two methene proton signal δ 1.74 (1H, m), 1.40 (1H, m),
1.95 (1H, m), 2.33 (1H, m).
13C H NMR spectroscopies (150MHz, CD3OD 17 carbon signals are provided in), low field area provides 10 sp2The carbon signal of hydridization,
It is the carbonyl carbon signals of one one-tenth ester wherein at δ 174.6, it at a carboxyl carbon signal δ 131.8,136.9 is a double bond to be at δ 170.3
Carbon signal.It is a phenyl ring carbon signal at δ 116.2,116.2,122.9,133.1,133.1,163.5.Provided at high field region δ 65.2
One connects the carbon signal of oxygen, and δ 21.4,29.2,29.9 provides three methyl carbon signals.
In HMBC spectrums (Figure 20), there is phase in δ 1.09 (3H, s), 1.21 (3H, s) and δ 29.9,36.6,48.4,136.9
Close, illustrate that the two methyl are connected on δ 36.6 quaternary carbon.δ 1.72 (3H, s) and δ 41.6,131.8,136.9 has long-range phase
Close, illustrate that this methyl is linked on δ 131.8 double key carbon.Related, the δ by δ 1.95 (1H, m) and δ 65.2,131.8,136.9
2.33 (1H, m) and δ 21.4,48.4,65.2,131.8,136.9 is related, δ 1.40 (1H, m) and δ 29.2,36.6,41.6,65.2
In the presence of long-range correlation, there is correlation, can draw structure fragment A in δ 1.74 (1H, m) and δ 36.6,65.2.By δ 6.84 (2H, dd, J
=2.4,8.4Hz) related, δ 7.90 (2H, dd, J=2.4,8.4Hz) and δ 116.2 with δ 116.2,122.9,133.1 be present,
133.1,163.5,170.3 have correlation, can draw structure fragment B.In addition, from being understood to the carbonyl carbon signals of High-Field displacement,
The carbonyl carbon is into ester.Therefore structure C can be drawn by A, B fragment.To sum up analyze, can determine that the compound structure for (4- hydroxyls-
2,6,6- trimethyls)-cyclohexenecarboxylic acid -4- hydroxyls-(benzoic acid) ester.
In CD is composed (see accompanying drawing 2), according to the spiral of unsaturated lactone rule, compound 2 presents negative at 233nm
Cotton effects, it can determine whether that 4 are R types, this [1] consistent with compound picrocrocinic acid configuration, therefore determine should
Compound is (4- hydroxyl -2,6,6- trimethyls)-cyclohexenecarboxylic acid -4- hydroxyls-(benzoic acid) ester.Retrieved through system documentation, be
Have no the noval chemical compound of document report.
The compound 3 of table 41H-(600MHz in CD3OD),13C-NMR(150MHz in CD3) and HMBC data OD
Embodiment 6:The Identification of chemical structure of compound 4
White powder (methanol), it is dissolved in methanol, Molisch reacting positives.HR-ESI-TOF-MS spectrums provide accurate point of high-resolution
Daughter ion peak m/z 521.2018 [M-H]-(Calcd.521.2023,-0.9ppm).With reference to its NMR data, its molecular formula is determined
For C26H34O11, and calculate the compound and contain 10 degrees of unsaturation.
1H H NMR spectroscopies (400MHz, CD3OD in) low field area provide 1 group of 1,3,4- trisubstituted benzene ring proton signals δ 6.90 (1H,
Br.s, H-2 "), 6.96 (1H, br.d, J=8.0Hz, H-5 "), 6.43 (1H, br.d, J=8.0Hz, H-6 "), 2 are trans double
Key proton signal δ 6.41 (1H, d, J=16.0Hz, H-8 "), δ 7.63 (1H, d, J=16.0Hz, H-7 "), 1 alkene Hydrogen Proton letter
Number δ 6.25 (1H, s, H-4).High field region provides 1 methoxy proton signal δ 3.87 (3H, s), 2 methyl proton signal δ 1.01
(3H, s), 1.11 (3H, s).By β-D-Glucose anomeric proton signal δ 4.44 (1H, d, J=8.0Hz, glc-1) and 6 protons
Signal δ 4.32 (1H, br.d, J=11.6Hz), 4.51 (1H, br.d, J=11.6Hz) are understood, a Portugal in the molecular structure be present
Grape glycan molecule, and 6 are acylated, and 1 is substituted.
13C H NMR spectroscopies (100MHz, CD3OD 26 carbon signals are provided in), low field area provides 12 sp2The carbon signal of hydridization,
A carbonyl carbon signals are wherein shown as at δ 202.9.Carbon signal is glucose end group carbon signal at δ 104.7.It is a first at δ 57.0
Epoxide carbon signal, another high field region provide two methyl carbon signal δ 27.6,29.5.
(Figure 21) is understood by HMBC spectrums, δ 6.41 (1H, d, J=16.0Hz, H-8 ") and δ 125.7,147.5,169.1 is present
Remotely related, there is long-range correlation in δ 7.63 (1H, d, J=16.0Hz, H-7 ") and δ 107.1,125.7,169.1, can draw one
Phenylpropenoyl structure fragment.δ 4.32 (1H, br.d, J=11.6Hz, glc-6), 4.51 (1H, br.d, J=11.6Hz, glc-
6) it is long-range related to the presence of δ 169.1, illustrate that glucose sugar 6 is acylated, be connected with phenylpropenoyl.By δ 4.47,4.53 with
There is correlation in δ 164.1,125.6, δ 3.83 and δ 36.4,50.7,164.1 has long-range correlation, δ 2.01,2.72 and δ 202.9,
36.4,50.7 is related, and δ 1.01,1.11 and δ 36.4,50.2,50.7 is related, can draw structure fragment A.δ 4.44 (1H, d, J=
8.0Hz, glc-1) long-range related, the deducibility glucose 1 and 10 methylol phases in said structure fragment to δ 72.2 be present
Even.To sum up analyze, can draw the relative configuration of the compound for 6'-O- (3 "-methoxyl group -4 "-hydroxyl-phenylpropenoyl)-β -
D-Glucose -1'-O-7- methyl-(6- methylol -1,1- dimethyleyelohexane -4- alkene -3- ketone) glycosides.
(accompanying drawing 4) is composed by CD to can be seen that, positive Cotton effects are presented at 235nm, 224nm and 207nm, are at 251nm
Now negative Cotton effects.It is beta configuration to understand that C-7 connects Oxymethylene and the one of methene protons of C-2 (δ 2.72), so
Judge the absolute configuration of the compound for R configurations[3].To sum up can conclude that the compound for (7R) -6 '-O- (3 "-methoxyl group -4 " -
Hydroxyl-phenylpropenoyl)-β-- the O-7- of D-Glucose -1 ' methylols-(6- methylol -1,1- dimethyleyelohexane -4- alkene -3- ketone)
Glycosides.
The compound 4 of table 51H-(400MHz in CD3OD),13C-NMR(100MHz in CD3) and HMBC data OD
Embodiment 7:The Identification of chemical structure of compound 5
Faint yellow indefinite form powder (methanol), is dissolved in methanol, Molisch reacting positives.HR-ESI-TOF-MS spectrums provide height
Differentiate quasi-molecular ion peak m/z 345.1540 [M-H]-(Calcd.345.1549,1.2ppm).With reference to its NMR data, it is determined that
Its molecular formula is C16H26O8, and calculate the compound and contain 4 degrees of unsaturation.
1H H NMR spectroscopies (400MHz, CD3OD 1, low field area alkene Hydrogen Proton signal δ 6.23 (1H, br.s, H-4) in).High field region
Provide 2 methyl proton signal δ 1.01 (3H, s), 1.11 (3H, s).By β-D-Glucose anomeric proton signal δ 4.25 (1H, d,
J=7.8Hz, glc-1) and 6 proton signal δ 3.67 (1H, dd, J=12.0,5.2Hz), 3.86 (1H, dd, J=12.0,
1.6Hz) understand, a glucose molecule in the molecular structure be present.
13C H NMR spectroscopies (100MHz, CD3OD 16 carbon signals are provided in), low field area provides 3 sp2The carbon signal of hydridization,
A carbonyl carbon signals are wherein shown as at δ 202.9.Carbon signal is glucose end group carbon signal at δ 104.6.Another high field region provides
Two methyl carbon signal δ 27.6,29.5.
(Figure 22) is understood by HMBC spectrums, related, δ 3.83 and δ 36.5 by δ 4.43,4.57 and δ 164.0,125.5 be present,
50.7,164.0 have long-range correlation, and δ 2.00,2.71 and δ 202.9,36.5,50.7 is related, δ 1.01,1.11 and δ 36.5,50.1,
50.7 is related, can draw structure fragment A.Long-range related, deducibility be present to δ 72.2 in δ 4.25 (1H, d, J=7.8Hz, glc-1)
The glucose 1 is connected with 10 methylols in said structure fragment.To sum up analyze, the relative configuration that can draw the compound is
3- methylol -4- methylol -5,5- dimethyleyelohexane -2- ketenes-β-D-Glucose glycosides.
(accompanying drawing 3) is composed by CD to can be seen that, positive Cotton effects are presented at 233nm and 208nm, are presented what is born at 329nm
Cotton effects.It is beta configuration to understand that C-7 connects Oxymethylene and the one of methene protons of C-2 (δ 2.71), so judging to be somebody's turn to do
The absolute configuration of compound is R configurations.To sum up can conclude that the compound is (4R) -3- methylol -4- methylol -5,5- dimethyl
Hexamethylene -2- ketenes-β-D-Glucose glycosides.Data above and document[2]Contrast, it is known that the compound and jasminoside B are each other
Isomer.
The compound 5 of table 61H-(400MHz in CD3OD),13C-NMR(100MHz in CD3) and HMBC data OD
Embodiment 8:The Identification of chemical structure of compound 14
Faint yellow solid (methanol), HR-ESI-TOF-MS spectrums provide the [M+ of high-resolution quasi-molecular ion peak m/z 156.0796
H]+(Calcd.156.0786,2.3ppm).With reference to its NMR data, it is C to determine its molecular formula8H12O3, and calculate the chemical combination
Thing contains 3 degrees of unsaturation.
1H NMR and13C NMR(600MHz,CD3OD a trans double bond signal δ is provided in) composingH7.29 (1H, t, J=
1.5Hz,H-3),δC130.8 (C-2), 151.2 (C-3), an aldehyde radical signal δH 9.75(1H,s,-CHO),δC 176.3(C-
1), a carbonyl carbon signals δC207 (C-6), two methyl carbon signal δH 2.18(3H,s,H-7),1.87(3H,s,2-CH3),δC
30.3(C-7),10.6(2-CH3), a mesomethylene carbon signal δH 2.87(2H,m,H-4),δC46.9 (C-4) and company's oxygen
Tertiary carbon signal δH 5.32(1H,m,H-5),δC 78.9(C-5)。
HMBC spectrums (Figure 23) prompting, δH 1.87(3H,s,2-CH3) and C-1, C-2, C-3 correlation, H-3 and C-1, C-2, C-4
Correlation, H-4 and C-3, C-5, C-6 are related, and H-7 is related in W to C-4, and H-7 and C-5, C-6 are related.The compound structure can be drawn
For (E) -5- hydroxy-2-methyls-hept-2-ene" -1,6- diketone.
The compound 14 of table 71H NMR(600MHz),13C NMR (150MHz) data
Embodiment 9:The Identification of chemical structure of compound 16
Yellow amorphous powder (methanol), it is dissolved in methanol, Molisch reacting positives.HR-ESI-TOF-MS spectrums provide accurate point
Daughter ion peak m/z 711.2508 [M+H]+(Calcd.711.2500,1.8ppm).And combine its NMR data, thus it is speculated that its molecule
Formula is C33H42O17, and calculate the compound and contain 13 degrees of unsaturation.
1H H NMR spectroscopies (400MHz, CD3OD) and13C H NMR spectroscopies (100MHz, CD3OD provided in) four double bond proton signals and
Six double bond carbon signals, wherein including a trans double bond signal δH7.63 (1H, d, J=16.0Hz, H-7 " '), 6.44 (1H, d,
J=16.0Hz, H-8 " '), δC147.4 (C-7 " '), 115.7 (C-8 " ').δH7.23 (2H, dd, J=2.0,8.0Hz, H-
2 " ', 6 " '), 6.80 (2H, dd, J=2.0,8.0Hz, H-3 " ', 5 " '), 3.87 (3H, s, 4 " '-OCH3) place's proton signal and δC
126.6 (C-1 " '), 159.6 (C-4 " '), 126.4 (C-2 " ', 6 " '), 115.3 (C-3 " ', 5 " '), 56.9 (4 " '-OCH3) place
Contain a dibasic phenyl ring of 1,4- in carbon signal prompting structure.
In HMBC spectrums (Figure 24), H-7 " ' and C-1 " ', C-2 " ', 6 " ', C-9 " ' is related, 4 " '-OCH3To C-4 " ' related,
H-8 " ' and C-9 " ', C-1 " ' is related, prompts a trans p- methoxybenzene acrylic acid groups be present.In addition, δH 4.40(1H,d,
J=8.0Hz, H-1 "), 4.53 (1H, br.d, J=10.8Hz, H-6 "), 4.22 (1H, dd, J=2.0,10.8Hz, H-6 ") and
δH4.71 (1H, d, J=8.0Hz, H-1 '), 4.09 (1H, dd, J=12.0,2.4Hz, H-6 '), 3.75 (1H, dd, J=
12.0,2.4Hz, H-6 ') two molecule glucoses be present in prompting structure, from anomeric proton coupling constant (8.0Hz), the Portugal
Grape sugar is beta configuration.H-6 ' is related with C-6 ' to C-1 " and H-1 ", and the connection for prompting two glucose is 1 → 6.Remaining1H、13C
NMR signal is similar to geniposide[8].H-1 is related to C-1 ' and H-1 ' with C-1, illustrates glucose 1 and 1 phase of Geniposide
Even.It is related by H-6 " to C-9 " ', and knowable to the C-6 to low field displacement " signals, p- methoxybenzene acrylic is connected to another
6 of glucose.1H H NMR spectroscopies (400MHz, CD3OD) and13C H NMR spectroscopies data and trans-p- hydroxyl-cinnamyl groups of 6 "-O--
Geniposide-O-gentibioside contrast, it is basically identical[4], therefore judge the compound for trans-p- methoxyl group-propenyl benzenes of 6 "-O-
Base-Geniposide-O-gentibioside.
The compound 16 of table 81H-(400MHz in CD3OD) and13C-NMR(100MHz in CD3OD) data
Embodiment 10:The Identification of chemical structure of compound 53
Yellow powder (methanol), ferric trichloride-potassium ferricyanide reacting positive, shows with the presence of phenolic hydroxyl group.UV(MeOH)λ
max(logε):204 (3.82), 254 (3.79), 294 (2.93), HR-ESI-TOF-MS spectrums provide quasi-molecular ion peak m/z
369.1175[M+H]+(Calcd.369.1186, -2.6ppm), with reference to13C NMR、1H H NMR spectroscopies, thus it is speculated that its molecular formula is
C17H20O9。
1H H NMR spectroscopies (400MHz, CD3OD low field area provides 2 aromatic signal δ 6.09 (1H, s, H-3), δ 6.24 in)
(1H,s,H-6).High field region shows 1 methoxy proton signal δ 3.97 (3H, s, 7-OCH3), 1 methyl proton signal δ 2.40
(3H,s,2-CH3), another δ 4.39 (1H, d, J=7.6Hz, glc-1 ') place is glucose anomeric proton signal.13C H NMR spectroscopies
(100MHz,CD3OD 17 carbon signals provided in), wherein low field area provide 9 sp2The carbon signal of hydridization, wherein at δ 184.5
For a carbonyl carbon signals.It is a methoxyl group carbon signal at high field region δ 56.8, is monomethyl carbon signal at δ 20.4, another δ 82.4,
One group of Glucose Carbon signal to High-Field displacement is provided at 80.0,74.9,72.8,71.7,62.9, thus can determine that the glucose
Carbon glycosides is formed with parent nucleus.In summary information will1H NMR,13C NMR datas and document[5]It is compared, it is seen that (the C- of δ 105.2
8) moved to low field, can determine whether that methoxyl group is connected in 7, therefore the deducibility compound is 7-methoxyl-5-hydroxy-2-
Methylchromone-8-C- β-D-glucopyranoside, i.e. 7- methoxyl group-Isobiflorins.
The compound 53 of table 91H-(400MHz in CD3OD) and13C-NMR(100MHz in CD3OD) data
Embodiment 11:Pharmacodynamic study
Green Bamboo Leaf Liquor carries out the acute liver protective effect research of different type of impairments and to normal and immunity
The Study immune regulation of low mouse.It protects the data of hepatic injury and Immune-enhancing effect as follows, illustrates to send out in Green Bamboo Leaf Liquor
The active ingredient for waving protection hepatic injury and immunological enhancement is active ingredient of the prior art:Terpene, iridoids are yellow
Ketone and flavonoid glycoside, chromogen ketone compounds, phenolic acid and phenolic glycoside class, aromatics, chinic acid class, Coumarins, lignanoids, steroid
Body class, alkaloids, Furanones, furfural class, any type in long-chain fat acids compound.
Carbon tetrachloride causes mouse chemical damage protective effect research
The data such as following table of hepatic injury caused by it protects carbon tetrachloride:
1 couple of CCl4Cause the influence of hepatic injury mice organs coefficient
Compared with normal group, liver coefficient, Spleen coefficient and the Kidney coefficients of model group hepatic injury mouse have rise, but
There was no significant difference.Compared with model group, liver coefficient, Spleen coefficient and the Kidney coefficients of Green Bamboo Leaf Liquor A-D groups have dropped
It is low, but there was no significant difference.
The Green Bamboo Leaf Liquor mother liquor of table 10 is to CCl4Cause hepatic injury mouse liver coefficient, Spleen coefficient and Kidney coefficients influence (N=10)
Note:*Contrasted with model group, P < 0.05;#Contrasted with blank group, P < 0.05
The influence of 2 pairs of serum ASTs, ALT, NO
CCl4Model group is compared with normal group, and the horizontal significantly rise (P < 0.01) of Serum ALT, AST, serum NO levels show
Write rise (P < 0.01).Show this experiment modeling success;Compared with model group, Green Bamboo Leaf Liquor mother liquor A-C groups are shown preferably
Active (P < 0.01, P < 0.05), it is especially preferable with B groups.D groups serum AST, ALT levels have lowered compared with model group, but nothing
Significant difference.Compared with model group, A-D group serum NO levels conspicuousness reduces (P < 0.01, P < 0.05), and F groups are without significantly
Sex differernce.Result above shows Green Bamboo Leaf Liquor mother liquor to CCl4The protective effect of caused acute liver is probably base
In terms of drop enzyme, anti-inflammatory.It the results are shown in Table 11.
The Green Bamboo Leaf Liquor mother liquor of table 11 is to CCl4Cause hepatic injury mice serum ALT, AST, NO influence (N=10)
Note:**Contrasted with model group, P < 0.01,*Contrasted with model group, P < 0.05;##To be contrasted with blank group, P <
0.01
T-AOC, GSH-PX influence in 3 pairs of hepatic tissues
CCl4For model group compared with normal group, hepatic tissue T-AOC, GSH-PX content significantly reduces (P < 0.01), shows this
Test modeling success;Compared with model group, Green Bamboo Leaf Liquor mother liquor A-D group hepatic tissue GSH-PX contents significantly raise (P <
0.01, P < 0.05);Hepatic tissue T-AOC contents significantly raise (P < 0.05) in Green Bamboo Leaf Liquor mother liquor B groups.Show Green Bamboo Leaf Liquor
Mother liquor can improve CCl4Cause the oxidation resistance of hepatic injury mouse.It the results are shown in Table 12.
The Green Bamboo Leaf Liquor mother liquor of table 12 is to CCl4Cause hepatic injury murine liver tissue in T-AOC, GSH-PX influence (N=
10)
Note:**Contrasted with model group, P < 0.01,*Contrasted with model group, P < 0.05;##To be contrasted with blank group, P <
0.01,#To be contrasted with blank group, P < 0.05.
SOD, MDA influence in 4 pairs of hepatic tissues
CCl4For model group compared with normal group, hepatic tissue SOD activity significantly reduces (P < 0.01), lipid peroxidation product
MDA contents significantly raise (P < 0.05), show this experiment modeling success.Compared with model group, Green Bamboo Leaf Liquor mother liquor A-D group livers
Tissue SOD's activity significantly raises (P < 0.01, P < 0.05);B, C groups lipid peroxidation product MDA contents are remarkably decreased (P <
0.05).Show that Green Bamboo Leaf Liquor mother liquor can reduce CCl4The lipid peroxidation product of induced mice, there is certain protective effect.
It the results are shown in Table 13.
Table 2-413 Green Bamboo Leaf Liquor mother liquors are to CCl4Cause hepatic injury murine liver tissue in SOD, MDA influence (N=10)
Note:**Contrasted with model group, P < 0.01,*Contrasted with model group, P < 0.05;##To be contrasted with blank group, P <
0.01,#To be contrasted with blank group, P < 0.05.
The influence of 5 pairs of hepatic tissue pathology changes
From changes in histopathology, Normal group liver cell is arranged radially centered on central vein, knot
Structure is normal;And CCl4Model group it is observed that serious Histopathologic change, such as:Centrilobular hepatic necrosis, macrophage, gas
Ball sample deforms and substantial amounts of inflammatory cell infiltration;Compound Liver-benepitino Remedy group and green bamboo snake mother liquor A-D dosage groups can significantly improve this
Hepatic tissue pathology changes, and as a result sees Fig. 6.
Thioacetamide causes mouse chemical damage protective effect research
1 Green Bamboo Leaf Liquor mother liquor causes the influence of hepatic injury mice organs coefficient to thioacetamide
Compared with normal group, the thymus gland coefficient conspicuousness of TAA model group hepatic injury mouse reduces (P < 0.01), liver system
Number has raised, but there was no significant difference, and there was no significant difference for Spleen coefficient, Kidney coefficients.Compared with model group, Green Bamboo Leaf Liquor
The thymus gland coefficient and Spleen coefficient of each dosage groups of mother liquor A-D there are no significant difference, the liver coefficient of Green Bamboo Leaf Liquor mother solution C group show
Work property reduces (P < 0.05), and there was no significant difference for the Kidney coefficients of each dosage group.Positive drug legalon group compared with model group,
Thymus gland coefficient, Spleen coefficient, liver coefficient, Kidney coefficients there are no significant difference.It the results are shown in Table 14.
The Green Bamboo Leaf Liquor mother liquor of table 14 causes hepatic injury mouse thymus coefficient, Spleen coefficient, liver coefficient, Kidney coefficients to TAA
Influence (N=10)
Note:**Contrasted with model group, P < 0.01,*Contrasted with model group, P < 0.05;##To be contrasted with blank group, P <
0.01.
The influence of 2 pairs of serum ASTs, ALT, TBIL
TAA model groups are compared with normal group, Serum ALT, the horizontal significantly rise (P < 0.01) of AST, TBIL.Show this examination
Test modeling success;Compared with model group, the horizontal conspicuousnesses of Green Bamboo Leaf Liquor mother liquor B-D groups ALT reduce (P < 0.01, P < 0.05).
The horizontal conspicuousness of each dosage groups AST, TBIL of A-D reduces (P < 0.05, P < 0.01).Show that Green Bamboo Leaf Liquor mother liquor is led to TAA
The mouse liver injury of cause has certain protective effect.Positive drug legalon group Serum ALT, TBIL compared with model group is horizontal
Conspicuousness reduces (P < 0.05, P < 0.01), the results are shown in Table 15.
The Green Bamboo Leaf Liquor mother liquor of table 15 TAA is caused hepatic injury mice serum ALT, AST, TBIL influence (N=10)
Note:**Contrasted with model group, P < 0.01,*Contrasted with model group, P < 0.05;##To be contrasted with blank group, P <
0.01.
GSH, T-AOC influence in 3 pairs of hepatic tissues
For TAA model groups compared with normal group, hepatic tissue GSH, T-AOC content significantly reduces (P < 0.01), hepatic tissue
SOD activity significantly reduces (P < 0.01), and lipid peroxidation product MDA contents significantly raise (P < 0.01), show that this experiment is made
Mould success;Compared with model group, Green Bamboo Leaf Liquor mother liquor A-D group hepatic tissue GSH contents significantly raise (P < 0.01, P <
0.05), SOD activity significantly raises (P < 0.01, P < 0.05);Each dosage group lipid peroxidation product MDA contents of B-D are notable
Decline (P < 0.01, P < 0.05), T-AOC contents significantly raise (P < 0.01, P < 0.05).Show that Green Bamboo Leaf Liquor mother liquor can carry
High TAA causes the oxidation resistance of hepatic injury mouse.It the results are shown in Table 16.
The Green Bamboo Leaf Liquor mother liquor of table 16 to TAA cause hepatic injury murine liver tissue in GSH, T-AOC, SOD, MDA influence (
N=10)
Note:**Contrasted with model group, P < 0.01,*Contrasted with model group, P < 0.05;##To be contrasted with blank group, P <
0.01.
4 Histopathology results
Pathological tissue interpretation of result, Normal group:Liver cell is arranged radially centered on central vein, and liver is small
Leaf, liver harden structure are normal, and without obvious cell infiltration, liver cell is without morphological changes such as denaturation, necrosis.Model control group:With
Centered on central vein, there is piece focal necrosis in surrounding hepatic tissue, and average each high power field 14, location of necrosis has different journeys
The cell infiltration of degree, large stretch of hepatic tissue liver cell enlargement, endochylema puffing, the expansion of part sinus hepaticus, there is a small amount of cell portal area
Infiltration.Green Bamboo Leaf Liquor mother liquor A-D groups:Compared with model group, necrosis of liver tissue stove is still piece focal necrosis, but area diminishes, and is in
Point, small pieces focal necrosis, location of necrosis have different degrees of cell infiltration, part hepatic tissue liver liver cell enlargement, and endochylema is dredged
Song Hua, sinus hepaticus have no obvious expansion, and there is a small amount of cell infiltration portal area, and it is more obvious that B, D group improve lesion.Compound Liver-benepitino Remedy
Group:There is spotty necrosis in hepatic tissue around the blood vessel of part, average each high power field 3, the infiltration of necrosis region visible inflammatory cell, quilt
Hepatic tissue liver cell enlargement under film, endochylema puffing, sinus hepaticus have no obvious expansion, and there is a small amount of cell infiltration portal area, sees figure
7。
Ethanol causes Alcoholic Hepatic Injury protective effect research
1 animal behavior is observed
All mouse are before gavage alcohol, and equal normal diet drinking-water, fur gloss is submissive, and bouncing, body weight has difference
Degree increase.After model group and each medicine group gavage alcohol, mostly astasia, walking is crooked, liquor-saturated soon sleeping, after a few houres from
Dynamic wake up turns, but diet and amount of drinking water have all been reduced, and fur tarnishes, One's spirits are drooping depressed, and it is in black to defecate, foul smelling,
Body weight loss.The animal state of medicine group is better than model group.
The influence of 2 pairs of alcohol induced Acute hepatic injury mice organs coefficients
Compared with normal group, the liver coefficient of model group significantly increases, and each medication therapy groups can significantly reduce liver
Coefficient, and be in dose dependent, enlargement (P < 0.01, the P < that wherein Green Bamboo Leaf Liquor mother solution C, two groups of D can significantly reduce liver
0.05), thus it is speculated that medicine group can mitigate oedema and the hyperemia of liver.The Spleen coefficient of model group has certain compared to normal group
Increase, prompt caused by Alcoholic that oedema and hyperemia may also occur in spleen in hepatic injury, cause quality to increase, each medicine
Treatment group and DDB group can be in various degree reduction Spleen coefficient, but there is no significant difference.Specific data are shown in Table
17。
The Green Bamboo Leaf Liquor mother liquor of table 17 causes hepatic injury mouse thymus coefficient, Spleen coefficient, liver coefficient and kidney system to alcohol
Several influence (N=10)
Note:**Contrasted with model group, P < 0.01,*Contrasted with model group, P < 0.05;##To be contrasted with blank group, P <
0.01.
The influence of 3 pairs of serum ASTs, ALT, TBIL
Alcohol model group is compared with normal group, Serum ALT, the horizontal significantly rise (P < 0.01) of AST, TBIL.Show this examination
Test modeling success;Compared with model group, Green Bamboo Leaf Liquor mother liquor A-D groups show preferably active (P < 0.01, P < 0.05), especially
It is preferable with B groups.Show that rise of the Green Bamboo Leaf Liquor mother liquor to the acute liver serum transaminase caused by alcohol has one
Fixed reduction effect.It the results are shown in Table 18.
The Green Bamboo Leaf Liquor mother liquor of table 18 alcohol is caused hepatic injury mice serum ALT, AST, TBIL influence (N=10)
Note:**Contrasted with model group, P < 0.01;##To be contrasted with blank group, P < 0.01.
GSH, T-AOC, SOD, MDA influence in 4 pairs of hepatic tissues
For alcohol model group compared with normal group, hepatic tissue T-AOC, SOD, GSH content significantly reduces (P < 0.01, P <
0.05), lipid peroxidation product MDA content significantly raises (P < 0.01), shows this experiment modeling success;With model group phase
Than Green Bamboo Leaf Liquor mother liquor B, C group hepatic tissue GSH contents significantly raise (P < 0.01, P < 0.05);C group hepatic tissues T-AOC contains
Amount significantly rise (P < 0.05);Hepatic tissue SOD contents significantly raise (P < 0.01, P < in Green Bamboo Leaf Liquor mother liquor A-D groups
0.05);A-D group lipid peroxidation product MDA contents significantly reduce, and show that Green Bamboo Leaf Liquor mother liquor can improve alcohol and cause hepatic injury small
The oxidation resistance of mouse, reduce the content of lipid peroxidation product.It the results are shown in Table 19.
The Green Bamboo Leaf Liquor mother liquor of table 19 to alcohol cause hepatic injury murine liver tissue in GSH, T-AOC, SOD, MDA influence (N=10)
Note:**Contrasted with model group, P < 0.01,*Contrasted with model group, P < 0.05;##To be contrasted with blank group, P <
0.01,#To be contrasted with blank group, P < 0.05.
The influence of 5 pairs of hepatic tissue pathology changes
From the point of view of histopathologic slide's result, Normal group lobuli hepatis structure is normal, no cell infiltration, liver cell with
It is arranged radially centered on central vein, liver cell is without morphological changes such as denaturation, necrosis.Model control group central vein week
Enclose hepatic tissue and piece focal necrosis occur, location of necrosis has different degrees of cell infiltration, large stretch of hepatic tissue liver cell enlargement, born of the same parents
Puffing is starched, the expansion of part sinus hepaticus, there is a small amount of cellular infiltration portal area.Green Bamboo Leaf Liquor mother liquor A-D groups, compared with model group, liver
Necrosis cooktop product reduces, and in point, small pieces focal necrosis, location of necrosis has different degrees of cell infiltration, part liver group
Liver liver cell enlargement, endochylema puffing are knitted, sinus hepaticus has no obvious expansion, and there is a small amount of cell infiltration portal area, and C groups improve lesion
It is more obvious.DDB positive controls, there is spotty necrosis, the leaching of necrosis region visible inflammatory cell in hepatic tissue around the blood vessel of part
Moistening, hepatic tissue liver cell enlargement under envelope, endochylema puffing, sinus hepaticus has no obvious expansion, and there is a small amount of cell infiltration portal area,
See Fig. 8.
The influence of 6 pairs of TNF-α expression
Experimental result shows, the expression without TNF-α in Normal group liver cell endochylema, model group murine liver tissue header
Express and significantly increase in liver cell endochylema by area and sinus hepaticus.Each dosage Green Bamboo Leaf Liquor mother liquor group, which has, significantly reduces TNF-α in liver
The effect of tissue expression, compared with model group, C, D group murine liver tissue TNF-α differential expression have significant statistical significance,
See Fig. 9.
The influence of 7 couples of Fas and FasL expression
Research shows that the Apoptosis of Fas System-mediateds is one of important mechanisms of hepatopathy occurrence and development.Hepatopathy virus exists
Surface of hepatocytes expression may one side cell cultured supernatant great expression Fas.On the other hand activation liver inner cell cytotoxic T cell
CTL great expression FasL, both, which combine, causes Apoptosis.The typically no Fas/FasL of normal liver expression, or have few
Measure Fas expression.Fas positive expressions are mainly expressed in endochylema, partly in after birth, and positive hepatocellular is primarily present in broken around leaflet
Consider sample necrotic area to be worth doing, Fas expression is associated with course inflammatory activity degree.This research finds with immunohistochemical staining, Mice normal liver
Dirty no Fas and FasL expression;Model group hepatic tissue Fas, FasL expression are substantially increased, and are expressed, are being drenched in extensive diffusivity
It is obvious around Ba Xibaojinrunqu.Fas antigens are mainly expressed in liver cytoplasm, brown yellow granule, are diffused and irregular, liver is thin
Also there is expression on cellular surface and sinusoidal endothelial cell surface:FasL expression is mainly based on endochylema, and minority is based on after birth, main collection
In around central vein, while also have a large amount of distributions in lobuli hepatis.After the pretreatment of Green Bamboo Leaf Liquor mother liquor, murine liver tissue
Damage mitigates, Fas and FasL antigen-positive cell numbers are reduced, and wherein C groups effect is the most obvious, relatively has with model group extremely aobvious
Statistical significance (the P of work<0.01) Green Bamboo Leaf Liquor mother liquor, is prompted to reach CTL pairs of blocking by suppressing Fas/FasL expression
The killing of liver cell, the hepatocellular apoptosis of alcohol induction is blocked, sees Figure 10, Figure 11.
The influence of 8 pairs of Bcl-2/Bax expression
Bcl-2 shows that Bcl-2 expresses in normal group height, model group low expression with Bax Immunohistochemical expression results,
In contrast, in normal group low expression, model group is high to be expressed Bax.And Green Bamboo Leaf Liquor mother liquor and positive controls Bcl-2 expression compared with
Model group strengthens, and Bax expression weakens compared with model group, prompts medicine to promote apoptosis by raising anti-apoptotic proteins Bcl-2 and lowering
Expressing to play Anti-G value for protein Bax, is shown in Figure 12, Figure 13.
Acetaminophen causes mouse drug induced hepatic injury protective effect research
1 Abensanil causes the influence of hepatic injury mice organs coefficient
Compared with normal group, the thymus gland coefficient conspicuousness of AP model group hepatic injury mouse reduces (P < 0.01), and hepatic injury is small
The liver coefficient of mouse significantly raises (P < 0.05), and Spleen coefficient conspicuousness rise (P < 0.01), Kidney coefficients are poor without conspicuousness
It is different.Compared with model group, the thymus gland coefficient of each dosage groups of Green Bamboo Leaf Liquor mother liquor A-D has raised, but without significant difference;Green bamboo snake
The liver coefficient conspicuousness of distiller's yeast liquid B, C group reduces (P < 0.05);The equal conspicuousness of Spleen coefficient of Green Bamboo Leaf Liquor mother liquor A-D groups
Reduce (P < 0.01);There was no significant difference for the Kidney coefficients of each dosage group.Positive drug DDB group is compared with model group, chest
Gland coefficient has raised, but there was no significant difference, and Spleen coefficient conspicuousness reduces (P < 0.01).It the results are shown in Table 20.
The Green Bamboo Leaf Liquor mother liquor Abensanil of table 20 causes hepatic injury mouse thymus coefficient, Spleen coefficient, liver coefficient and kidney
Coefficient influence (N=10)
Note:**Contrasted with model group, P < 0.01,*Contrasted with model group, P < 0.05;##To be contrasted with blank group, P <
0.01.
The influence of 2 pairs of serum ASTs, ALT, TBIL
AP model groups are compared with normal group, Serum ALT, the horizontal significantly rise (P < 0.01) of AST, TBIL.Show this experiment
Modeling success;Compared with model group, the ALT levels of Green Bamboo Leaf Liquor mother liquor B, C dosage group significantly reduce (P < 0.05, P <
0.01), AST, TBIL level of each dosage groups of Green Bamboo Leaf Liquor mother liquor A-D significantly reduce (P < 0.01), show green bamboo snake distiller's yeast
Liquid has protective effect to the mouse drug induced hepatic injury caused by AP.Positive drug DDB group is compared with model group, serum
AST, TBIL level significantly reduce (P < 0.01), the results are shown in Table 21.
The Green Bamboo Leaf Liquor mother liquor of table 21 AP is caused hepatic injury mice serum ALT, AST, TBIL influence (N=10)
Note:**Contrasted with model group, P < 0.01,*Contrasted with model group, P < 0.05;##To be contrasted with blank group, P <
0.01.
GSH, T-AOC, SOD, MDA influence in 3 pairs of hepatic tissues
Compared with normal group, hepatic tissue GSH, T-AOC content significantly reduces (P < 0.01) AP model groups, and hepatic tissue SOD lives
Property significantly reduces (P < 0.01), and lipid peroxidation product MDA contents significantly raise (P < 0.01), show this experiment modeling into
Work(.Compared with model group, each dosage group hepatic tissue GSH, T-AOC contents of Green Bamboo Leaf Liquor mother liquor B-D significantly rise (P < 0.05,
P < 0.01), each dosage group hepatic tissue SOD activity of Green Bamboo Leaf Liquor mother liquor A-D significantly raises (P < 0.01), lipid peroxidation production
Thing MDA contents are remarkably decreased (P < 0.05, P < 0.01), show that Green Bamboo Leaf Liquor mother liquor can improve the antioxygen that AP causes hepatic injury mouse
Change ability, caused lipid peroxidation product MDA in course of liver damage is removed, there is certain protection to make to drug induced hepatic injury
With.Positive drug DDB group is compared with model group, and GSH, T-AOC content significantly raise (P < 0.05, P < in hepatic tissue
0.01), SOD activity significantly raises (P < 0.01), and lipid peroxidation product MDA contents are remarkably decreased (P < 0.01).As a result
It is shown in Table 22.
The Green Bamboo Leaf Liquor mother liquor Abensanil of table 22 cause hepatic injury murine liver tissue in GSH, T-AOC, SOD, MDA influence (N=10)
Note:**Contrasted with model group, P < 0.01,*Contrasted with model group, P < 0.05;##To be contrasted with blank group, P <
0.01.
Con A cause immunological liver injury protective effect research
1 experimental animal general status
ICR mouse are successfully induced to establish acute hepatic injury model with Con A.Model group mouse tail vein injection Con A
After (20mg/kg) 4h, autonomic activities significantly reduces, and no resistance is One's spirits are drooping, rolls up in cage, extraneous acousto-optic is stimulated ineffective
It is quick, to look for food less, urine is yellow, and individual mice hair is upright, but without death in 8h.
2 couples of Con A cause the influence of hepatic injury mice organs coefficient
Compared with normal group, the thymus gland coefficient conspicuousness of Con A model group hepatic injury mouse reduces (P < 0.01), spleen
Coefficient, liver coefficient conspicuousness rise (P < 0.01), there was no significant difference for Kidney coefficients.Compared with model group, green bamboo snake distiller's yeast
Two groups of liquid B, C thymus gland coefficient conspicuousness rise (P < 0.01), the equal conspicuousness drop of Spleen coefficient of Green Bamboo Leaf Liquor mother liquor A-D groups
Low (P < 0.01);The equal conspicuousness of liver coefficient of each dosage groups of Green Bamboo Leaf Liquor mother liquor A-D reduces (P < 0.01), each dosage group
There was no significant difference for Kidney coefficients.Compared with model group, thymus gland coefficient has raised positive drug DDB group, but without conspicuousness
Difference, Spleen coefficient conspicuousness reduce (P < 0.01).It the results are shown in Table 23.
The Green Bamboo Leaf Liquor mother liquor of table 23 causes hepatic injury mouse thymus coefficient, Spleen coefficient, liver coefficient and kidney system to Con A
Several influence (N=10)
Note:**Contrasted with model group, P < 0.01;##To be contrasted with blank group, P < 0.01.
The influence of 3 pairs of serum ASTs, ALT, TBIL
Experimental result shows, tail vein injection ConA after 8 hours compared with normal group, Con A model groups Serum ALT,
The horizontal significantly rise (P < 0.01) of AST, TBIL, shows this experiment modeling success.Compared with model group, Green Bamboo Leaf Liquor mother liquor B, C
Two groups of the horizontal conspicuousness reduction groups of ALT (P < 0.05, P < 0.01), there was no significant difference for the ALT levels that two groups of A, D;The leaf of bamboo
The horizontal conspicuousnesses of AST, TBIL of blue or green distiller's yeast liquid A-D groups reduce (P < 0.01), and result of the test shows Green Bamboo Leaf Liquor mother liquor pair
Mouse liver injury caused by Con A has protective effect.Compared with model group, positive drug group serum AST, TBIL are horizontal significantly
Reduce (P < 0.05, P < 0.01), the results are shown in Table 24.
The Green Bamboo Leaf Liquor mother liquor of table 24 Con A are caused hepatic injury mice serum ALT, AST, TBIL influence (N=10)
Note:**Contrasted with model group, P < 0.01,*Contrasted with model group, P < 0.05;##To be contrasted with blank group, P <
0.01.
GSH, T-AOC, SOD, MDA influence in 4 pairs of hepatic tissues
For Con A model groups compared with normal group, hepatic tissue GSH, T-AOC content significantly reduces (P < 0.01), hepatic tissue
SOD activity significantly reduces (P < 0.01), and lipid peroxidation product MDA contents significantly raise (P < 0.01), show this experiment mould
Type success.Compared with model group, Green Bamboo Leaf Liquor mother liquor A-D group hepatic tissue GSH, T-AOC content significantly raise (P < 0.05, P
< 0.01), SOD activity significantly raises (P < 0.01);Hepatic tissue lipid peroxidation product MDA contents are remarkably decreased (P <
0.01), show that Green Bamboo Leaf Liquor mother liquor has certain protective effect to Con A induced mice immunological liver injuries.Positive drug group
Compared with model group, GSH, T-AOC content significantly raise (P < 0.01), and SOD activity significantly raises (P < 0.01);Lipid mistake
Oxidation product MDA contents are remarkably decreased (P < 0.01).It the results are shown in Table 25.
The Green Bamboo Leaf Liquor mother liquor of table 25 to Con A cause hepatic injury murine liver tissue in GSH, T-AOC, SOD, MDA influence (N=10)
Note:**Contrasted with model group, P < 0.01,*Contrasted with model group, P < 0.05;##To be contrasted with blank group, P <
0.01.
Immune-enhancing activity is studied
The influence of 1 pair of normal and hypoimmunity mouse weight, thymus gland coefficient and Spleen coefficient
Compared with normal group, body weight, thymus gland coefficient and the Spleen coefficient of model group mouse substantially reduce (P < 0.01, P
< 0.05), especially thymus gland coefficient reduces significantly (P < 0.01), prompts caused by cyclophosphamide hypoimmunity model modeling
Success.Compared with normal group, normal mouse is after green bamboo snake mother liquor is given, body weight, thymus gland coefficient and the spleen system of each group mouse
Number does not have significant difference.Compared with model group, the thymus gland coefficient of the hypoimmunity mouse of Green Bamboo Leaf Liquor A-F groups significantly rises
High (P < 0.01, P < 0.05);A, two groups of B Spleen coefficient significantly raises (P < 0.05);And the body weight of hypoimmunity mouse
There was no significant difference compared with model group, the results are shown in Table 26.
The Green Bamboo Leaf Liquor mother liquor of table 26 to normal and hypoimmunity mouse weight, thymus gland coefficient and Spleen coefficient influence (N=10)
Note:**Contrasted with model group, P < 0.01,*Contrasted with model group, P < 0.05;##To be contrasted with blank group, P <
0.01,#To be contrasted with blank group, P < 0.05.
2 pairs of normal and the mouse liver coefficient of hypoimmunity and influences of Kidney coefficients
Compared with normal group, the rise of model group mouse liver coefficient, but there was no significant difference;Kidney coefficients rise presents aobvious
Write sex differernce (P < 0.05).After normal mouse gives Green Bamboo Leaf Liquor mother liquor, its liver, Kidney coefficients are compared with normal group without aobvious
Write sex differernce.Compared with model group, liver, the Kidney coefficients of hypoimmunity mouse significantly reduce (P < 0.01, P <
0.05) 27, be the results are shown in Table.
The Green Bamboo Leaf Liquor mother liquor of table 27 to normal and hypoimmunity mouse liver, Kidney coefficients influence (N=10)
Note:**Contrasted with model group, P < 0.01,*Contrasted with model group, P < 0.05;#To be contrasted with blank group, P <
0.05.
3 couples of serum I FN- γ, IL-6 and LSZ influence
For model group compared with normal group, IL-6, IFN-γ content are remarkably decreased (P < 0.01) in serum, illustrate this experiment
Modeling success.Normal mouse is after the Green Bamboo Leaf Liquor mother liquor of A-F dosage groups is given, compared with normal group, in addition to E, F group, remaining
Each dosage group blood serum IL-6, IFN-γ content have raised.Wherein, Green Bamboo Leaf Liquor mother liquor A, B groups IL-6 contents rise compared with
For notable (P < 0.01), there was no significant difference for remaining group.
In addition, the low mouse of endoxan immunogenicity is after the Green Bamboo Leaf Liquor mother liquor of A-F dosage groups is given, with model group
Compare, each dosage group blood serum IL-6, IFN-γ content have raised.Wherein, A-D dosage groups blood serum IL-6, IFN-γ content
With significant difference (P < 0.01) compared with model group.It is normal and immune that data above illustrates that Green Bamboo Leaf Liquor mother liquor can strengthen
The cell factor IL-6, IFN-γ of the low mouse of power secretion, so as to strengthen autoimmunity, the results are shown in Table 3-3.
In addition, serum lysozyme is to be synthesized by macrophage and can be promptly released into a kind of extracellular important hydrolase,
It is a kind of important nospecific immunity factor of body defenses.This experimental evaluation ZYQL is to mice serum lysozyme activity
Influence, the results are shown in Table 28, compared with normal group, mouse independent gavage Green Bamboo Leaf Liquor mother liquor 200mg/kg and 400mg/kg, serum
Antalzyme activity has different degrees of raising, has significant difference (P<0.05, P<0.01) green bamboo snake distiller's yeast, is individually given
During liquid 50mg/kg and 100mg/kg dosage, there was no significant difference for serum lysozyme level;After Cy is injected intraperitoneally, with normal control
Group is compared, and serum lysozyme level significantly reduces (P<0.01);Compared with Cy groups, each dosage group serum lysozymes of ZYQL+Cy are lived
Power has different degrees of lifting (P<0.05, P<0.01), wherein 200mg/kg Green Bamboo Leaf Liquor mother liquor coordinates Cy effect pole
Significantly (P<0.01).
The Green Bamboo Leaf Liquor mother liquor of table 28 is to IFN-γ in normal and hypoimmunity mice serum, the shadow of IL-6 and LSZ contents
Ring (N=10)
Note:**Contrasted with model group, P < 0.01,*Contrasted with model group, P < 0.05;##To be contrasted with blank group, P <
0.01
SOD, GSH-PX, CAT influence in 4 pairs of spleen tissues
Model group is compared with normal group, and GSH-PX, CAT content and SOD activity, significantly reduce (P < in spleen tissue
0.01) this experiment immunodeficiency models modeling success, is illustrated.Normal mouse awards the Green Bamboo Leaf Liquor mother liquor of various concentrations in gavage
After (A-F groups), in spleen tissue, GSH-PX, CAT content and SOD activity significantly rise (P < 0.01, P < 0.05), illustrate bamboo
Leaf green grass or young crops wine can improve normal mouse vivo oxidation activities of antioxidant enzymes, so as to strengthen mouse immunity of organisms.As shown in Table 29, bamboo
Leaf green grass or young crops mother liquor B, C group is compared with other group positive effects.
In addition, Green Bamboo Leaf Liquor mother liquor can also improve GSH-PX, CAT in caused by cyclophosphamide hypoimmunity Mice Body
The activity of content and SOD, compared with model group, there is significant difference (P < 0.01, P < 0.05), the results are shown in Table 29.
The Green Bamboo Leaf Liquor mother liquor of table 29 to SOD, GSH-PX, CAT in normal and hypoimmunity mouse boosting tissue influence (N=10)
Note:**Contrasted with model group, P < 0.01,*Contrasted with model group, P < 0.05;##To be contrasted with blank group, P <
0.01,#To be contrasted with blank group, P < 0.05.
Influence (carbon particle clearance) of the 5 Green Bamboo Leaf Liquor mother liquors to mouse monokaryon mononuclear phagocyte system phagocytic function
After injecting Cy (100mg/kg), compared with Normal group, mouse phagocyte imdex significantly reduces Cy groups.With just
Normal group compares, and individually gives 400mg/kg Green Bamboo Leaf Liquor mother liquor, and mouse phagocyte imdex can be made to raise (P<0.05).With mould
Type group is compared, immunosupress caused by 100mg/kg, 200mg/kg, 400mg/kg Green Bamboo Leaf Liquor mother liquor can resist Cy, can
Significantly improve phagocyte imdex (P<0.05, P<0.01) 30, be the results are shown in Table.
Influence (n=10) of the Green Bamboo Leaf Liquor mother liquor of table 30 to mouse monokaryon mononuclear phagocyte system phagocytic function
Note:**Contrasted with model group, P < 0.01,*Contrasted with model group, P < 0.05;#To be contrasted with blank group, P <
0.05.
Embodiment 12:Bioactivity research
Any one compound carries out anti-inflammatory, cholinolytic ester in effective monomer chemical composition compound 1-78 in the present invention
Enzyme, hepatocyte protective effect research.Result of study shows, it is thin that anti-inflammatory, anticholinesterase, Vitro hepatic are played in Green Bamboo Leaf Liquor
The active ingredient of born of the same parents' protective effect is any one in compound 1-78 involved in the present invention.
Its anti-inflammatory, anticholinesterase, hepatocyte protective effect result such as following table 31:
Each monomeric compound extracorporeal anti-inflammatory of table 31, anticholinesterase and hepatocyte protection activity
aEach monomeric compound concentration is 50 μ Μ
bLiver protective effect positive controls
cAnti-inflammatory activity positive controls
dAnti- AChE active controls group
Bibliography
[1]Straubinger,M.,Bau,B.,Eckstein,S.,Fink,M.,Winterhalter,
P..Identification of novel glycosidic arom a precursors in Saffron(Crocus
sativus L.).J Agric Food Chem.1998,46,3238-3243.
[2]Quan Cheng Chen,UiJoung Youn,Byung-Sun Min,and KiHwan Bae,Pyronane
Monoterpenoids from the Fruit of Gardenia jasminoides,J.Nat.Prod.2008,71,995-
999.
[3]Kai,N.K..Shin Jikken Kagaku Koza 13,Yuki kozo(Ⅱ),Maruzen,Tokyo,
1977,pp.821-830.
[4]Yu,Y.,Xie,Z.L.,Gao,H.,Ma,W.W.,Dai,Y.,Wang,Y.,Zhong Y.,Yao,X.S.,
Bioactive Iridoid Glucosides from the Fruit of Gardenia jasminoides.Journal
of Natural Products 2009,72,1459-1464.
[5]Okamurα,N.,Hine,N.,Tateyamα,Y.,Nakazawα,M.,Fujiokα,T.,Mihashi,K.,
Yagi,A.,Five chromones from Aloe Vera leaves,Phytochemistry,1998,49,219-223.
Claims (7)
- A kind of 1. following compound of isolated structural formula from Green Bamboo Leaf Liquor:
- 2. application of the compound in liver protection, the medicine of Immune-enhancing effect, health products and food is prepared described in claim 1.
- 3. compound described in claim 1 prepare liver protection, Immune-enhancing effect functional food in application.
- 4. a kind of pharmaceutical composition, contain the compound described in claim 1.
- 5. a kind of health-care food composition, contain the compound described in claim 1.
- 6. the pharmaceutical composition described in claim 4, is prepared into pharmaceutical dosage forms as needed, it is selected from:Oral dosage form, Injection form, external preparation form, suppository form.
- 7. the health-care food composition described in claim 5, it is characterised in that the food compositions are selected from:Beverage, dairy products, Cake, candy.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510312849.7A CN104961782B (en) | 2013-10-22 | 2013-10-22 | Bioactive ingredients and its medical usage in Green Bamboo Leaf Liquor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310501283.3A CN103554124B (en) | 2013-10-22 | 2013-10-22 | Bioactive ingredients in bamboo leaf green wine and medicinal use |
CN201510312849.7A CN104961782B (en) | 2013-10-22 | 2013-10-22 | Bioactive ingredients and its medical usage in Green Bamboo Leaf Liquor |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310501283.3A Division CN103554124B (en) | 2013-10-22 | 2013-10-22 | Bioactive ingredients in bamboo leaf green wine and medicinal use |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104961782A CN104961782A (en) | 2015-10-07 |
CN104961782B true CN104961782B (en) | 2017-12-19 |
Family
ID=50008521
Family Applications (8)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510314168.4A Active CN104926894B (en) | 2013-10-22 | 2013-10-22 | Bioactive ingredients and medicinal usage in Green Bamboo Leaf Liquor |
CN201510314424.XA Active CN104926891B (en) | 2013-10-22 | 2013-10-22 | Bioactive ingredients and medicinal usage in Green Bamboo Leaf Liquor |
CN201510312849.7A Active CN104961782B (en) | 2013-10-22 | 2013-10-22 | Bioactive ingredients and its medical usage in Green Bamboo Leaf Liquor |
CN201510314135.XA Active CN105037336B (en) | 2013-10-22 | 2013-10-22 | Bioactive ingredients and purposes in Green Bamboo Leaf Liquor |
CN201510312850.XA Active CN105111251B (en) | 2013-10-22 | 2013-10-22 | Bioactive ingredients and medical usage in Green Bamboo Leaf Liquor |
CN201510314425.4A Active CN104945449B (en) | 2013-10-22 | 2013-10-22 | Bioactive ingredients and its medical usage in Green Bamboo Leaf Liquor |
CN201310501283.3A Active CN103554124B (en) | 2013-10-22 | 2013-10-22 | Bioactive ingredients in bamboo leaf green wine and medicinal use |
CN201510314170.1A Active CN105016995B (en) | 2013-10-22 | 2013-10-22 | Bioactive component in trimeresurus wine and pharmaceutical uses thereof |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510314168.4A Active CN104926894B (en) | 2013-10-22 | 2013-10-22 | Bioactive ingredients and medicinal usage in Green Bamboo Leaf Liquor |
CN201510314424.XA Active CN104926891B (en) | 2013-10-22 | 2013-10-22 | Bioactive ingredients and medicinal usage in Green Bamboo Leaf Liquor |
Family Applications After (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510314135.XA Active CN105037336B (en) | 2013-10-22 | 2013-10-22 | Bioactive ingredients and purposes in Green Bamboo Leaf Liquor |
CN201510312850.XA Active CN105111251B (en) | 2013-10-22 | 2013-10-22 | Bioactive ingredients and medical usage in Green Bamboo Leaf Liquor |
CN201510314425.4A Active CN104945449B (en) | 2013-10-22 | 2013-10-22 | Bioactive ingredients and its medical usage in Green Bamboo Leaf Liquor |
CN201310501283.3A Active CN103554124B (en) | 2013-10-22 | 2013-10-22 | Bioactive ingredients in bamboo leaf green wine and medicinal use |
CN201510314170.1A Active CN105016995B (en) | 2013-10-22 | 2013-10-22 | Bioactive component in trimeresurus wine and pharmaceutical uses thereof |
Country Status (1)
Country | Link |
---|---|
CN (8) | CN104926894B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106990196A (en) * | 2017-05-15 | 2017-07-28 | 福建农林大学 | It is a kind of at the same detect euscaphis konishii medicinal material in isbiflorin and biflorin method |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0990439A4 (en) * | 1997-05-22 | 2004-01-28 | Kyowa Hakko Kogyo Kk | Bisaryl compounds and cancer remedies containing the same |
JPH11302272A (en) * | 1998-04-21 | 1999-11-02 | Sankyo Co Ltd | Benzyl c-glycoside compound as selection inhibitor |
JP2006069982A (en) * | 2004-09-03 | 2006-03-16 | Kinjirushi Kk | Compound originating from genuine japanese horse radish having antioxidation activity |
WO2009051840A2 (en) * | 2007-10-18 | 2009-04-23 | Yale University | Compositions and methods for reducing hepatotoxicity associated with drug administration |
CN100564340C (en) * | 2008-02-02 | 2009-12-02 | 兰州大学 | (2E, 4E)-preparation method of 2-methyl-6-oxo-2 |
CN101613264B (en) * | 2008-06-27 | 2013-12-04 | 中国科学院广州生物医药与健康研究院 | Annulenone compounds and application thereof in preparing anti-tumor medicaments |
US9415035B2 (en) * | 2010-09-17 | 2016-08-16 | Maine Natural Health Company, Inc. | Compositions containing omega-3 oil with an anti-inflammatory agent and uses thereof |
-
2013
- 2013-10-22 CN CN201510314168.4A patent/CN104926894B/en active Active
- 2013-10-22 CN CN201510314424.XA patent/CN104926891B/en active Active
- 2013-10-22 CN CN201510312849.7A patent/CN104961782B/en active Active
- 2013-10-22 CN CN201510314135.XA patent/CN105037336B/en active Active
- 2013-10-22 CN CN201510312850.XA patent/CN105111251B/en active Active
- 2013-10-22 CN CN201510314425.4A patent/CN104945449B/en active Active
- 2013-10-22 CN CN201310501283.3A patent/CN103554124B/en active Active
- 2013-10-22 CN CN201510314170.1A patent/CN105016995B/en active Active
Non-Patent Citations (3)
Title |
---|
Melanogenesis inhibitory activity of monoterpene glycosides from Gardeniae Fructus;Toshihiro Akihisa et al.;《Chemistry & Biodiversity》;20120817;第9卷(第8期);第1490-1499页 * |
Monoterpenoids from the fruit of Gardenia jasminoides.;Yang Yu et al.;《Helvetica Chimica Acta》;20100430;第93卷(第4期);第763-771页 * |
栀子化学成分的UHPLC-Q-TOFMS分析;王晓燕等;《中药材》;20130331;第36卷(第3期);第407-410页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105037336B (en) | 2017-10-31 |
CN104961782A (en) | 2015-10-07 |
CN104926891B (en) | 2018-06-05 |
CN105037336A (en) | 2015-11-11 |
CN105111251B (en) | 2017-12-19 |
CN103554124A (en) | 2014-02-05 |
CN104926891A (en) | 2015-09-23 |
CN104945449B (en) | 2017-10-24 |
CN105016995A (en) | 2015-11-04 |
CN105016995B (en) | 2017-03-22 |
CN104926894A (en) | 2015-09-23 |
CN104945449A (en) | 2015-09-30 |
CN104926894B (en) | 2017-10-31 |
CN105111251A (en) | 2015-12-02 |
CN103554124B (en) | 2015-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Song et al. | Cistanches Herba, from an endangered species to a big brand of Chinese medicine | |
TWI421085B (en) | An anti-cancer active substance from antrodia camphorata, method for preparing the same and use thereof | |
CN103768151B (en) | Flos Osmanthi Fragrantis phenethyl alcohol glycoside extract is preparing the application in antiaging agent or health product | |
US8168238B2 (en) | Extracts of Aquilaria hulls and use thereof in the treatment of cancer | |
Huang et al. | Hypoglycemic constituents isolated from Trapa natans L. pericarps | |
Bailly | The traditional and modern uses of Selaginella tamariscina (P. Beauv.) Spring, in medicine and cosmetic: Applications and bioactive ingredients | |
CN105943532A (en) | Application of diterpenoid compound to preparation of medicament for treating liver cancer | |
Vestena et al. | Hepatoprotective activity of Verbena litoralis, Verbena montevidensis and their main iridoid, brasoside | |
Sayed et al. | Antiproliferative potential of Physalis peruviana-derived magnolin against pancreatic cancer: A comprehensive in vitro and in silico study | |
Plančić et al. | Phytochemical profile and biological activities of the genus Ornithogalum L.(Hyacinthaceae) | |
CN106008543A (en) | Novel diterpenoid compound and preparation method thereof | |
CN104961782B (en) | Bioactive ingredients and its medical usage in Green Bamboo Leaf Liquor | |
Yin et al. | 13C-NMR-based MixONat strategy coupled with 2D NMR for rapid dereplication and identification of new secondary metabolites from Aloe vera | |
CN108164574B (en) | Compound in caulis Sinomenii, and preparation method and application thereof | |
CN102838570B (en) | Mailuoning ester and preparation method and function thereof | |
CN106109459A (en) | The pharmaceutical composition of dipivefrine hydrochloride and the application in biological medicine thereof | |
CN108084009A (en) | A kind of compound in Sabia parviflora Wall.ex Roxb and preparation method and application | |
CN111529515A (en) | Application of 12, 15-dioxo-alpha-cnidiene in pharmacy | |
CN106366155A (en) | Novel limonins compound as well as preparation method and medical application thereof | |
CN106008216A (en) | Pharmaceutical composition of didanosine and application of pharmaceutical composition in biological medicines | |
Pan et al. | Polygonati Rhizoma: A review on the extraction, purification, structural characterization, biosynthesis of the main secondary metabolites and anti-aging effects | |
CN104288169A (en) | Flavone glycoside compound and preparation method and application thereof | |
Xu et al. | A novel Vestitain A from the ripe fruits of Embelia vestita Roxb. | |
CN111388457A (en) | Application of 3' -geranyl citrus chalcone and composition in preparation of product for treating fatty liver | |
CN108358986A (en) | A kind of flavone compound and preparation method thereof and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |